Amgen Technology Private Limited - Due diligence report

A 360° intelligence report on Amgen Technology Private Limited: trust score, financial health, credit view, compliance, directors, growth an…

2007-03-08 Mumbai, Maharashtra Active Unlisted Active Compliant
Share
Connect MCP
AT Amgen Technology Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Amgen Technology Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
84/100
Trust Score
Low Risk

Amgen Technology Private Limited is assessed as Low Risk with a Trust Score of 84/100. Amgen Technology Private Limited is an active private limited foreign company incorporated in india incorporated in 2007, operating in the Research & Development sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and low financial risk profile.

Report generated on 09 Aug 2026 from the latest processed filings. Amgen Technology Private Limited snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
84/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
88/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
75/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
90/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
85/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
70/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
75/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 90/100 Low Risk
  • Liabilities ≈ 38% EBITDA - serviceable.
  • No open charges - unencumbered balance sheet.
  • Working-capital cover adequate.
  • Profitable - internal accruals available.

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 88/100 Low Risk
  • Company status is Active as per MCA.
  • Balance sheet slightly behind (Mar 2024).
  • 1 active GST registration(s).
05

Director Intelligence

Stability score: 85/100
NameDIN / PANDesignationAppointedTenureDIN status
MANSI JAYANTILAL MALKAN 01234567 Director 01/04/2018 6 yrs Approved
David Ewan Foulstone 01234567 Director 01/04/2018 6 yrs Approved
NG LIAN ERIC TECK 01234567 Director 01/04/2018 6 yrs Approved
NAVEEN GULLAPALLI 01234567 Director 01/04/2018 6 yrs Approved
Mihir Kumar Ojha 01234567 Director 01/04/2018 6 yrs Approved
  • 5 directors on the board.
  • No disqualified or deactivated DINs.
  • 2 director exit(s) in the last 3 years.
Director & KMP remuneration (FY 2023)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2023 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
Amgen Worldwide Holdings B V
Subsidiaries
-
Group entities
-
Capital events
-

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Group entityRelationship% held
Amgen Worldwide Holdings B V Holding Company 74.00%

Key managerial personnel: NAVEEN GULLAPALLI (Whole-time director) · Mihir Kumar Ojha (Whole-time director)

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 70 · Distress 75
Growth signals & trust indicators
Revenue acceleration: +1.42 over 4 year(s).
Operating for 19+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Revenue declined year-on-year.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence83/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 1 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment85/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance record supports lending.
Investor view75/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 1 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
09 May 2025
Director appointed
Mihir Kumar Ojha (Whole-time director)
23 Apr 2025
Director appointed
NAVEEN GULLAPALLI (Whole-time director)
30 Sep 2024
Last AGM held
Annual general meeting
25 Sep 2024
Director ceased
David Ewan Foulstone
31 Mar 2024
Latest balance sheet
Filed with ROC
20 Mar 2024
Director appointed
David Ewan Foulstone (Director)
29 Sep 2023
Director ceased
SHALABH SACHDEVA
22 Dec 2020
Director ceased
VINOD MATTOO
31 Mar 2020
Director ceased
SONIKA SHAH
20 Jul 2018
Director ceased
SAGAR PRABHAKAR PATIL
30 Sep 2017
Director ceased
MANSI JAYANTILAL MALKAN
Director ceased
NG LIAN ERIC TECK
15 Sep 2017
Director appointed
MANSI JAYANTILAL MALKAN (Director)
31 Aug 2017
Director appointed
NG LIAN ERIC TECK (Director)
31 May 2017
Director ceased
MICHAEL AARON KELLY
10

Key Observations

Auto-generated from the data above
Revenue grew 2.1x over the last 4 financial year(s).
Net profit margin moved from 24% to 0.86.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
5 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2023 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Genepath Dx U74999PN2019PTC181759 Pune, Maharashtra, India
Finoso U24231TG2009PTC064774 Hyderabad, Telangana, India
Intonation Research Laboratories Private Limited U73200TG2013PTC087978 Hyderabad, Telangana, India
Jasmine Bio Labs Private Limited U74999TG2017PTC115223 Medchal Mandal, Telangana, India
Premier Research U73100KA2021FTC143738 Bengaluru, Karnataka, India
Pharmaffilates U24232HR2006PTC036410 Panchkula, Haryana, India
Cornelius U29130KA2005PTC035967 Bangalore North, Karnataka, India
Promega U51102MH2013PTC248556 Mumbai, Maharashtra, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Amgen Technology Private Limited before audits and certifications: compliance score 88/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Amgen Technology Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Favourable lending indicators. Credit risk score 90/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 70/100, margin trends, ownership structure and peer set for Amgen Technology Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 84/100, distress signals and MSME payment-delay disclosures - know whether Amgen Technology Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Amgen Technology Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Amgen Technology Private Limited an active company?

Amgen Technology Private Limited has MCA status “Active” with a compliance score of 88/100 (Low Risk).

Is Amgen Technology Private Limited financially healthy?

Amgen Technology Private Limited has a Financial Health Score of 75/100 (Low Risk) based on its filed financial statements.

Should I do business with Amgen Technology Private Limited?

Its overall Trust Score is 84/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Amgen Technology Private Limited?

The ultimate holding entity is Amgen Worldwide Holdings B V. 5 active director(s) are on record.

Does Amgen Technology Private Limited have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Amgen Technology Private Limited up to date with its ROC filings?

Balance sheet slightly behind (Mar 2024). Overall compliance score: 88/100 (Low Risk).

Is it risky to lend to Amgen Technology Private Limited?

Its Credit Risk Score is 90/100 (Low Risk). Banker verdict: Favourable lending indicators.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.